CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −100 | $124.44 | $12K | 97,656 |
| 2022-01-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −3 | $125.00 | $375 | 97,653 |
| 2022-01-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −17,000 | 409,000 | ||
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +3,037 | $11.48 | $35K | 937,255 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −1,000 | $138.86 | $139K | 936,255 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −3,100 | $139.82 | $433K | 933,155 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −5,368 | $140.96 | $757K | 927,787 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −2,932 | $141.72 | $416K | 924,855 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −700 | $143.11 | $100K | 924,155 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −1,400 | $144.78 | $203K | 922,755 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Sale | −500 | $145.33 | $73K | 922,255 |
| 2022-01-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −3,037 | 45,559 | ||
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 48,819 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Sale | −3,583 | $145.16 | $520K | 45,236 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Sale | −4,083 | $145.96 | $596K | 41,153 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Sale | −1,334 | $146.92 | $196K | 39,819 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Sale | −500 | $148.04 | $74K | 39,319 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Sale | −500 | $149.18 | $75K | 38,819 |
| 2022-01-03 | McAnear Justin J. Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 350,159 | ||
| 2022-01-03 | Hindson Benjamin J. | Exercise or conversion | +2,084 | $11.48 | $24K | 162,770 |
Page 16 of 23 · 456 trades